BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 1516235)

  • 1. Unusual manifestations of primary cutaneous amyloidosis in association with Raynaud's phenomenon and livedo reticularis.
    Naldi L; Marchesi L; Locati F; Berti E; Cainelli T
    Clin Exp Dermatol; 1992 Mar; 17(2):117-20. PubMed ID: 1516235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Part II: Cutaneous manifestations of peripheral vascular disease.
    Raja A; Karch J; Shih AF; De La Garza H; De Zepeda Diaz AJ; Maymone MBC; Phillips TJ; Secemsky E; Vashi N
    J Am Acad Dermatol; 2023 Aug; 89(2):211-226. PubMed ID: 35504485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Raynaud's phenomenon as initial manifestation of cutaneous polyarteritis nodosa.
    Andreu-Sanchez JL; Martin-Santos JM; Isasi-Zaragoza C; Trujillo-Castellanos A; Cuende-Quintana E; Mulero J
    Ann Rheum Dis; 1991 Jan; 50(1):48-50. PubMed ID: 1671636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary localized cutaneous nodular amyloidosis associated with CREST (calcinosis, Raynaud's phenomenon, esophageal motility disorders, sclerodactyly, and telangiectasia) syndrome.
    Shiman M; Ricotti C; Miteva M; Kerdel F; Romanelli P
    Int J Dermatol; 2010 Feb; 49(2):229-30. PubMed ID: 20465653
    [No Abstract]   [Full Text] [Related]  

  • 5. Livedo reticularis and Raynaud's phenomenon associated with cryoglobulinaemia but not related to hepatitis C virus in an HIV-1-positive patient.
    Muñoz-Pérez MA; Rodriguez-Pichardo A; Camacho F; Colmenero MA
    Eur J Dermatol; 1998; 8(5):357-8. PubMed ID: 9683872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti blood group-M autoantibodies with livedo reticularis, Raynaud's phenomenon, and anaemia.
    Sangster JM; Kenwright MG; Walker MP; Pembroke AC
    J Clin Pathol; 1979 Feb; 32(2):154-7. PubMed ID: 438345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atrophie blanche. Clinical diagnosis and treatment.
    Elisaf M; Nikou-Stefanaki S; Drosos AA; Moutsopoulos HM
    Ann Med Interne (Paris); 1991; 142(6):415-8. PubMed ID: 1772181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic algorithm for Raynaud's phenomenon and vascular skin lesions in systemic lupus erythematosus.
    Richter JG; Sander O; Schneider M; Klein-Weigel P
    Lupus; 2010 Aug; 19(9):1087-95. PubMed ID: 20693202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The blue man: a novel cutaneous manifestation of systemic amyloidosis.
    Campbell M; Rosenthal A; Kundranda M; Pickert A; Dicaudo D; Dogan A; Mikhael J
    Amyloid; 2011 Sep; 18(3):156-9. PubMed ID: 21506660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cutaneous manifestations of systemic lupus erythematosus.
    Yell JA; Mbuagbaw J; Burge SM
    Br J Dermatol; 1996 Sep; 135(3):355-62. PubMed ID: 8949425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Mucocutaneous lesions in patients with systemic lupus erythematosus].
    Saurit V; Campana R; Ruiz Lascano A; Ducasse C; Bertoli A; Agüero S; Alvarellos A; Caeiro F
    Medicina (B Aires); 2003; 63(4):283-7. PubMed ID: 14518140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary localised cutaneous amyloidosis in systemic sclerosis.
    Black MM
    Trans St Johns Hosp Dermatol Soc; 1971; 57(1):177-80. PubMed ID: 5570256
    [No Abstract]   [Full Text] [Related]  

  • 13. Raynaud's phenomenon in systemic lupus erythematosus.
    Lavras Costallat LT; Valente Coimbra AM
    Rev Rhum Engl Ed; 1995 May; 62(5):349-53. PubMed ID: 7655867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cold agglutinin disease--the importance of cutaneous signs.
    Läuchli S; Widmer L; Lautenschlager S
    Dermatology; 2001; 202(4):356-8. PubMed ID: 11455160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vasospastic disorders.
    Metzler M; Silver D
    Postgrad Med; 1979 Feb; 65(2):79-84, 87-8. PubMed ID: 419023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mucocutaneous disease in Arabs with systemic lupus erythematosus: clinical expression and relevance to autoantibodies.
    Al-Attia HM; Al Ahmed YH
    Lupus; 1998; 7(8):535-9. PubMed ID: 9863895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of Raynaud's disease.
    Cooke JP; Marshall JM
    Vasc Med; 2005 Nov; 10(4):293-307. PubMed ID: 16444858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lichen amyloidosis, ankylosing spondylitis and autoimmune thyroiditis: coincidence or association?
    Apaydin R; Bilen N; Bayramgürler D; Harova G; Cetinarslan B
    J Eur Acad Dermatol Venereol; 2000 Mar; 14(2):135-7. PubMed ID: 10972101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unusual skin manifestation of cutaneous amyloidosis.
    Hung CC; Wang CM; Hong HS; Kuo TT
    Dermatology; 2003; 207(1):65-7. PubMed ID: 12835553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macular amyloidosis with widespread diffuse pigmentation.
    Wang CK; Lee JY
    Br J Dermatol; 1996 Jul; 135(1):135-8. PubMed ID: 8776378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.